Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Article  PubMed  Google Scholar 

Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol. 2012;3(3):153–73.

PubMed  PubMed Central  Google Scholar 

Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159–70.

Article  CAS  PubMed  Google Scholar 

Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature. 1997;386(6625):623–7.

Article  CAS  PubMed  Google Scholar 

Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res. 1994;54(19):5059–63.

CAS  PubMed  Google Scholar 

Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96(15):8681–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malki A, ElRuz RA, Gupta I, Allouch A, Vranic S, Al Moustafa AE. Molecular mechanisms of Colon cancer progression and metastasis: recent insights and advancements. Int J Mol Sci 2020, 22(1).

Harada T, Matsumoto S, Hirota S, Kimura H, Fujii S, Kasahara Y, Gon H, Yoshida T, Itoh T, Haraguchi N, et al. Chemically modified antisense oligonucleotide against ARL4C inhibits primary and metastatic liver Tumor Growth. Mol Cancer Ther. 2019;18(3):602–12.

Article  CAS  PubMed  Google Scholar 

Matsumoto S, Fujii S, Sato A, Ibuka S, Kagawa Y, Ishii M, Kikuchi A. A combination of wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures. EMBO J. 2014;33(7):702–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujii S, Matsumoto S, Nojima S, Morii E, Kikuchi A. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target. Oncogene. 2015;34(37):4834–44.

Article  CAS  PubMed  Google Scholar 

Fujii S, Shinjo K, Matsumoto S, Harada T, Nojima S, Sato S, Usami Y, Toyosawa S, Morii E, Kondo Y, et al. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3’-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma. Oncotarget. 2016;7(49):81571–87.

Article  PubMed  PubMed Central  Google Scholar 

Hu Q, Masuda T, Sato K, Tobo T, Nambara S, Kidogami S, Hayashi N, Kuroda Y, Ito S, Eguchi H, et al. Identification of ARL4C as a peritoneal Dissemination-Associated Gene and its clinical significance in gastric Cancer. Ann Surg Oncol. 2018;25(3):745–53.

Article  PubMed  Google Scholar 

Xia L, Ge M, Shan G, Qian H, Xia Y. The Effects of circ_000558/miR-1225-5p/ARL4C on Regulating the Proliferation of Renal Cell Carcinoma Cells. J Oncol 2023, 2023:1303748.

Yang J, Peng S, Zhang K. ARL4C depletion suppresses the resistance of ovarian cancer to carboplatin by disrupting cholesterol transport and autophagy via notch-RBP-Jkappa-H3K4Me3-OSBPL5. Hum Exp Toxicol. 2022;41:9603271221135064.

Article  CAS  PubMed  Google Scholar 

Zhang P, Xu Y, Chen S, Wang Z, Zhao L, Chen C, Kang W, Han R, Qiu J, Wang Q, et al. ARL4C regulates the progression of Clear Cell Renal Cell Carcinoma by affecting the Wnt/beta-Catenin signaling pathway. J Oncol. 2022;2022:2724515.

PubMed  PubMed Central  Google Scholar 

Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, El Zimaity H, Flejou JF, Hansen TP, Hartmann A, et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017;30(9):1299–311.

Article  PubMed  Google Scholar 

Rogers AC, Winter DC, Heeney A, Gibbons D, Lugli A, Puppa G, Sheahan K. Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer. Br J Cancer. 2016;115(7):831–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamakura M, Uehara T, Iwaya M, Asaka S, Kobayashi S, Nakajima T, Kinugawa Y, Nagaya T, Yoshizawa T, Shimizu A, et al. LGR5 expression and clinicopathological features of the invasive front in the fat infiltration area of pancreatic cancer. Diagn Pathol. 2022;17(1):21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kawachi H, Eishi Y, Ueno H, Nemoto T, Fujimori T, Iwashita A, Ajioka Y, Ochiai A, Ishiguro S, Shimoda T, et al. A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study. Mod Pathol. 2015;28(6):872–9.

Article  PubMed  Google Scholar 

Aruga N, Kijima H, Masuda R, Onozawa H, Yoshizawa T, Tanaka M, Inokuchi S, Iwazaki M. Epithelial-mesenchymal transition (EMT) is correlated with patient’s prognosis of lung squamous cell carcinoma. Tokai J Exp Clin Med. 2018;43(1):5–13.

CAS  PubMed  Google Scholar 

Federmann B, Frauenfeld L, Pertsch H, Borgmann V, Steinhilber J, Bonzheim I, Fend F, Quintanilla-Martinez L. Highly sensitive and specific in situ hybridization assay for quantification of SOX11 mRNA in mantle cell lymphoma reveals association of TP53 mutations with negative and low SOX11 expression. Haematologica. 2020;105(3):754–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujii S, Ishibashi T, Kokura M, Fujimoto T, Matsumoto S, Shidara S, Kurppa KJ, Pape J, Caton J, Morgan PR, et al. RAF1-MEK/ERK pathway-dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation. J Pathol. 2022;256(1):119–33.

Article  CAS  PubMed  Google Scholar 

Xie N, Bai Y, Qiao L, Bai Y, Wu J, Li Y, Jiang M, Xu B, Ni Z, Yuan T, et al. ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments. J Cell Mol Med. 2021;25(8):4014–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hofmann I, Thompson A, Sanderson CM, Munro S. The Arl4 family of small G proteins can recruit the cytohesin Arf6 exchange factors to the plasma membrane. Curr Biol. 2007;17(8):711–6.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Du J, Zheng J, Liu J, Xu R, Shen T, Zhu Y, Chang J, Wang H, Zhang Z, et al. EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells. Oncotarget. 2015;6(9):7244–61.

Article  PubMed  PubMed Central  Google Scholar 

Harada A, Matsumoto S, Yasumizu Y, Shojima K, Akama T, Eguchi H, Kikuchi A. Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion. Elife 2021, 10.

Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, Nabi IR. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res. 2010;70(9):3780–90.

Article  CAS  PubMed  Google Scholar 

Shinto E, Mochizuki H, Ueno H, Matsubara O, Jass JR. A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci. Histopathology. 2005;47(1):25–31.

Article  CAS  PubMed  Google Scholar